课题基金 / 基金详情

SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I

SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
I 型神经纤维瘤病的体细胞突变分析
批准号:
6218415
负责人:
DAVID H. VISKOCHIL
金额:
$0.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

DAVID H. VISKOCHIL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objectives of this project are to determine the role of NF1 mutant alleles in the phenotype of NF1 and to dissect the biochemical pathways involved in tumor progression in NF1-related tumors. Two hypothesizes are being tested. The first is that specific features of NF1 are more commonly found in individuals who have similar NF1 mutations. The second hypothesis is that mutations occur in NF1-related tumors which affect pathways involved in tumor progression. The investigators have now collected 26 NF1 patients and DNA extraction and EBV-transformation has been accomplished in the core laboratory. NF1 mutations have been detected in five patients although only eight individuals have been comprehensively screened. Current strategies are aimed at selecting NF1 cohorts with similar phenotypes in order to increase the likelihood that a specific mutation can be detected if there are allele-specific clinical features. Several manuscripts describing this work have been published.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: MPS II PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
  • 批准号:
    7718513
  • 项目类别:
  • 资助金额:
    $0.07万
  • 财政年份:
    2008
  • 负责人:
    DAVID H. VISKOCHIL
  • 依托单位:
CLINICAL GENETICS RESEARCH PROGRAM
  • 批准号:
    7718483
  • 项目类别:
  • 资助金额:
    $1.2万
  • 财政年份:
    2008
  • 负责人:
    DAVID H. VISKOCHIL
  • 依托单位:
CLINICAL GENETICS RESEARCH PROGRAM
  • 批准号:
    7604941
  • 项目类别:
  • 资助金额:
    $7.67万
  • 财政年份:
    2007
  • 负责人:
    DAVID H. VISKOCHIL
  • 依托单位:
MPS II PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
  • 批准号:
    7604971
  • 项目类别:
  • 资助金额:
    $0.44万
  • 财政年份:
    2007
  • 负责人:
    DAVID H. VISKOCHIL
  • 依托单位:
海外基金